With the priority area Health Sciences, JMU covers basic, diseases-oriented and patient-oriented research including health services research. The Health Sciences are anchored in the Medical Faculty and the University Hospital.
JMU aims for an early translation of research results into clinical applications for optimized and personalized therapies, concentrating on the areas oncology, cardiovascular diseases, infection and immunity, biomaterials and regenerative medicine as well as neurology and mental health. To spur this process, JMU has established specialized centers which involve tight collaborations between biomedical groups at the university and clinicians at the University Hospital.
The Comprehensive Cancer Center (CCC) Mainfranken, funded by the Deutsche Krebshilfe (German Cancer Aid), the Center for Personalized Molecular Immunotherapy, and the Early Clinical Trial Unit located in the Department of Hematology/Oncology provide excellent conditions for joint research, personalized therapies, and the execution of clinical trials.
The Comprehensive Heart Failure Center supported by the Federal Ministry for Education and Research pursues an interdisciplinary concept of research, teaching, and care for patients with heart diseases. The Translation Network for the Research and Diagnosis of Thrombo-Inflammatory Diseases elaborates, in close cooperation with regional companies, methods for diagnosis and develops new medicines for the treatment of patients.
Already in 1993/1994, with the foundation of the Institute for Molecular Infection Biology (IMIB) and the Research Center for Infectious Diseases (ZINF) JMU specialized in research on infection diseases. Just recently, this area has been further strengthened by the foundation of the Helmholtz Institute for RNA-based Infection Research (HIRI) which started operation in 2017.
The Musculoskeletal Center Würzburg, the Fraunhofer Institute for Regenerative Therapies for Oncology and Musculoskeletal Diseases, the Bavarian Polymer Institute, and the Center for Locomotion Research address research on biomaterials and regenerative medicine with the intention to enhance and establish new treatment strategies for musculoskeletal diseases and to improve patient care quality.
The Mental Health Center strives for optimal care, therapy, and follow-up-support for patients with mental diseases. Additionally, the prevention of appearing and recurring mental illnesses is a central goal.
With funding by the Federal Ministry for Education and Research, an Interdisciplinary Bank of Biomaterials and Data Würzburg has been set up which supplies patient material for preclinical research on different diseases.